Patent · US Active

Method for generating a genetically modified pig with inactivated porcine endogenous retrovirus (PERV) elements

US12058986B2 · kind B2 · utility

0Cited by
73References
30Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 20, 2018
Grant dateAug 13, 2024
Priority date
Expiry dateNov 29, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides methods of generating multiplexed genetically modified animals, for example, porcine endogenous retrovirus (PERV)-inactivated pigs. The disclosure also provides methods of improving the birth rate of multiplexed genetically modified animals. In some embodiments, the present closure is concerned with the generation and utilization of porcine cells in which porcine endogenous retroviral (PERV) elements have been inactivated. In sonic embodiments, the PERV-free or PERV-reduced porcine cells are cloned to produce porcine embryos. In some embodiments, the PERV-free or PERV-reduced embryos may be grown into adult swine from which organs and/or tissues may be extracted and used for such purposes as xenotransplantation into non-porcine animals such as humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.